A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide rebates for drugs furnished under Medicare part B for which the growth in average sales price has exceeded inflation, and for other purposes.
About This Bill
Committee
Latest Action · July 10, 2019
Read twice and referred to the Committee on Finance.